BR112017008070A8 - Composição farmacêutica para elevar o trofismo da mucosa nasal - Google Patents

Composição farmacêutica para elevar o trofismo da mucosa nasal

Info

Publication number
BR112017008070A8
BR112017008070A8 BR112017008070A BR112017008070A BR112017008070A8 BR 112017008070 A8 BR112017008070 A8 BR 112017008070A8 BR 112017008070 A BR112017008070 A BR 112017008070A BR 112017008070 A BR112017008070 A BR 112017008070A BR 112017008070 A8 BR112017008070 A8 BR 112017008070A8
Authority
BR
Brazil
Prior art keywords
nasal mucosa
trophism
elevate
pharmaceutical composition
composition
Prior art date
Application number
BR112017008070A
Other languages
English (en)
Other versions
BR112017008070A2 (pt
BR112017008070B1 (pt
Inventor
Panin Giorgio
Testa Domenico
Guerra Germano
Original Assignee
Bio Lo Ga Srl
Hulka S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51951918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017008070(A8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Lo Ga Srl, Hulka S R L filed Critical Bio Lo Ga Srl
Publication of BR112017008070A2 publication Critical patent/BR112017008070A2/pt
Publication of BR112017008070A8 publication Critical patent/BR112017008070A8/pt
Publication of BR112017008070B1 publication Critical patent/BR112017008070B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSIÇÃO FARMACÊUTICA PARA ELEVAR O TROFISMO DA MUCOSA NASAL. Composição para aplicação tópica, para uso no aumento do trofismo da mucosa nasal compreendendo um éster de vitamina E com um ácido carboxílico da fórmula R-COOH, em que R é um radical alquila apresentando 1 a 19 átomos de carbono ou um radical alquenila ou alquinila apresentando 2 a 19 átomos de carbono e um veículo oleoso; tal composição podendo ser usada para o tratamento de rinite atrófica crônica e para obtenção de reparação tecidual da mucosa nasal após cirurgia nasal e sinusal.
BR112017008070-2A 2014-10-22 2015-10-02 Composição farmacêutica para elevar o trofismo da mucosa nasal BR112017008070B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20141819 2014-10-22
ITMI2014A001819 2014-10-22
PCT/EP2015/072796 WO2016062522A1 (en) 2014-10-22 2015-10-02 Pharmaceutical composition for use in increasing the trophism of nasal mucosa

Publications (3)

Publication Number Publication Date
BR112017008070A2 BR112017008070A2 (pt) 2018-02-20
BR112017008070A8 true BR112017008070A8 (pt) 2022-07-05
BR112017008070B1 BR112017008070B1 (pt) 2023-07-04

Family

ID=

Also Published As

Publication number Publication date
US10226444B2 (en) 2019-03-12
EA033078B1 (ru) 2019-08-30
HRP20191989T1 (hr) 2020-02-07
SI3209294T1 (sl) 2019-12-31
HUE047203T2 (hu) 2020-04-28
ES2757349T3 (es) 2020-04-29
GEP20186863B (en) 2018-06-11
EA201790447A1 (ru) 2017-09-29
PL3209294T3 (pl) 2020-01-31
RS59496B1 (sr) 2019-12-31
CA2965184A1 (en) 2016-04-28
LT3209294T (lt) 2019-10-25
BR112017008070A2 (pt) 2018-02-20
CY1122289T1 (el) 2021-01-27
MX2017005195A (es) 2017-10-04
EP3209294B1 (en) 2019-08-21
DK3209294T3 (da) 2019-10-28
EP3209294A1 (en) 2017-08-30
AU2015335204B2 (en) 2020-10-08
WO2016062522A1 (en) 2016-04-28
AU2015335204A1 (en) 2017-04-13
CN107438429A (zh) 2017-12-05
US20170290799A1 (en) 2017-10-12
CL2017000971A1 (es) 2018-01-12
PT3209294T (pt) 2019-10-08

Similar Documents

Publication Publication Date Title
CY1122289T1 (el) Φαρμακευτικη συνθεση για χρηση στην αυξηση του τροφισμου της ρινικης βλεννογονου
BR112017007072A2 (pt) compostos de triazolopiridina e métodos para o tratamento de fibrose cística
DOP2013000239A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso.
BR112016027041A8 (pt) combinações farmacêuticas para tratamento do câncer
AR094964A1 (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRASTORNOS RELACIONADOS CON LA FOSFOINOSITIDA 3-CINASA d (PI3Kd)
BR112014026703A2 (pt) inibidores de dna-pk
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
GT201300320A (es) Terapia de combinación que comprende un inhibidor de cdk4/6 y un inhibidor de pi3k para el uso en el tratamiento de cáncer.
BR112013031402A2 (pt) derivados de hidantoína como inibidores de kv3
BR112016028845A2 (pt) composto, composição farmacêutica e uso de um composto
CR20150432A (es) Estra-1,3,5 (10), 16-tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
BR112016004118A2 (pt) uso de inibidores da acetil-coa carboxilase para tratamento de acne vulgar
AR079945A1 (es) Derivados de pirazina como inhibidores de glucogeno sintasa quinasa 3 (gsk3)
BR112015020222A2 (pt) compostos de azetidiniloxifenilpirrolidina
MX2016006727A (es) Composiciones farmaceuticas con actividad hidratante y lubricante.
BR112015014262A8 (pt) formulação farmacêutica, dispositivo adaptado para distribuição intranasal de uma formulação farmacêutica, e, uso de uma formulação farmacêutica
BR112015021865A8 (pt) pró-drogas de derivados de nitróxido multifuncionais e usos das mesmas.
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
CL2016000397A1 (es) Tratamiento contra el cáncer
BR112014005730A2 (pt) método de tratar carcinoma mucoepidermóide
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
BR112014022687A8 (pt) uso de uma quantidade eficaz de r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo, composição farmacêutica, r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo
EA201992190A1 (ru) Состав на основе витамина е или его сложного эфира для лечения бактериальных и грибковых биопленок
BR112012018906A2 (pt) materiais e acessórios para a aplicação da terapia fotodinâmica antibacteriana
BR112015022970A2 (pt) composição farmacêutica de cloridrato de s-cetamina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B25A Requested transfer of rights approved

Owner name: HULKA S.R.L. (IT)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/10/2015, OBSERVADAS AS CONDICOES LEGAIS